1.74 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Palisade Bio, Inc. Common Stock
PALINASDAQ • USD
1.75
↗ 0.01 (0.58%)
POST MARKET (AS OF 07:33 PM EDT)
Post Market
AS OF 07:33 PM EDT
1.75
↗ 0.01 (0.58%)
Market: CLOSED
Open?$1.93
High?$1.94
Low?$1.66
Prev. Close?$1.74
Volume?4.3M
Avg. Volume?2.9M
VWAP?$1.75
Rel. Volume?1.47x
Bid / Ask
Bid?$1.74 × 5.8K
Ask?$1.76 × 5.0K
Spread?$0.02
Midpoint?$1.75
Valuation & Ratios
Market Cap?302.4M
Shares Out?173.6M
Float?165.0M
Float %?99.4%
P/E Ratio?N/A
P/B Ratio?2.37
EPS?-$0.14
Dividend?0.00%
Ex-Dividend?N/A
Palisade Bio, Inc. Common Stock (PALI) trades at $1.74 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, PALI appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Employees
14
Market Cap
302.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-04-28
Address
7750 EL CAMINO REAL, SUITE 5200
CARLSBAD, CA 92009
Phone: (858) 704-4900
CARLSBAD, CA 92009
Phone: (858) 704-4900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?29.26Safe
Confidence?45%Low
Short InterestVery High
Short % of Float?16.32%High
Short Interest?26.9M
Days to Cover?10.4
Free Float165.0M
Avg Daily Volume2.6M
Settlement Date2026-05-15
Financial Health
Current Ratio?23.71Strong
Quick Ratio?23.71Strong
Cash Ratio?23.60Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.37CHEAP▾
Peers100
S&P67
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-6.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-19.0%WEAK▾
S&P8
ROA?-18.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$169.7M
Fundamentals ratios updated end of day